ALGS Q4 2021 Earnings — Aligos Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

ALGSAligos Therapeutics, Inc.

$45M

Q4 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$367,000

Gross Profit

$367,000100.0% margin

Operating Income

-$38M-10340.1% margin

Net Income

-$38M-10276.3% margin

EPS (Diluted)

$-0.89

QoQ Revenue Growth

-76.1%

Cash Flow

Operating Cash Flow

-$37M

Free Cash Flow

-$38M

Stock-Based Comp.

$4M

Balance Sheet

Total Assets

$235M

Total Liabilities

$51M

Stockholders' Equity

$185M

Cash & Equivalents

$187M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$367,000	$0	—
Gross Profit	$367,000	$0	—
Operating Income	-$38M	-$34M	-10.7%
Net Income	-$38M	-$34M	-9.6%